Anping Li

Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.

Correction: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.

Journal: Journal of hematology & oncology

Published: December 13, 2022

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.

Journal: Journal of hematology & oncology

Published: November 29, 2020

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: June 13, 2020

RDGN-based predictive model for the prognosis of breast cancer.

RDGN-based predictive model for the prognosis of breast cancer.

Journal: Experimental hematology & oncology

Published: May 26, 2020

The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.

The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017.

Journal: Journal of hematology & oncology

Published: May 06, 2020

Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017.

Global burden and trend of acute lymphoblastic leukemia from 1990 to 2017.

Journal: Aging

Published: May 06, 2020

The role of cancer-derived microRNAs in cancer immune escape.

The role of cancer-derived microRNAs in cancer immune escape.

Journal: Journal of hematology & oncology

Published: November 30, 2019

Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.

Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.

Journal: Integrative cancer therapies

Published: September 14, 2019

CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer.

CXCL1 as an Unfavorable Prognosis Factor Negatively Regulated by DACH1 in Non-small Cell Lung Cancer.

Journal: Frontiers in oncology

Published: August 30, 2019

Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis.

Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis.

Journal: BioMed research international

Published: July 10, 2019

Prospects for combining immune checkpoint blockade with PARP inhibition.

Prospects for combining immune checkpoint blockade with PARP inhibition.

Journal: Journal of hematology & oncology

Published: July 03, 2019

SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1.

SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1.

Journal: Frontiers in oncology

Published: April 30, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026